Literature DB >> 8902114

Microbial contamination of antiseptics and disinfectants.

S Oie1, A Kamiya.   

Abstract

BACKGROUND: There have been a number of reports on microbial contamination of antiseptics and disinfectants. At present, however, the necessity of measures to prevent contamination do not seem to be fully appreciated. We investigated microbial contamination of antiseptics and disinfectants that are used in our hospital.
METHODS: Fifty-one samples of benzalkonium chloride and chlorhexidine gluconate that were being used in the hospital were examined. Viability of the contaminants detected in these samples was also tested in the agents. Then we examined measures to prevent contamination of these agents.
RESULTS: Microbial contamination was detected at 10(2) to 10(7) CFU/ml in the following samples: 6 of 23 samples of cotton balls soaked in 0.02% benzalkonium chloride kept in a canister for antisepsis and disinfection (26.1%); 7 of 13 samples of 0.02%, benzalkonium chloride or 0.02% chlorhexidine gluconate in an irrigation apparatus kept at 37 degrees C for vaginal douching (53.8%); and 9 of 15 samples of 0.02% benzalkonium chloride or 0.05% chlorhexidine gluconate for storage of suction catheters in a plastic bottle (60%). The major contaminants were Burkholderia cepacia, Pseudomonas aeruginosa, Xanthomonas maltophilia, and Pseudomonas fluorescens. The first two organisms examined grew in the agents. After improvements in the handling of the antiseptics and disinfectants, no microbial contamination was observed.
CONCLUSIONS: It is necessary to check microbial contamination of diluted benzalkonium chloride and diluted chlorhexidine gluconate that are in use. Such products are not recommended as antiseptics.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8902114     DOI: 10.1016/s0196-6553(96)90027-9

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  13 in total

1.  Exceptionally high representation of Burkholderia cepacia among B. cepacia complex isolates recovered from the major Portuguese cystic fibrosis center.

Authors:  Mónica V Cunha; Ana Pinto-de-Oliveira; Luís Meirinhos-Soares; Maria José Salgado; José Melo-Cristino; Susana Correia; Celeste Barreto; Isabel Sá-Correia
Journal:  J Clin Microbiol       Date:  2007-03-14       Impact factor: 5.948

2.  Type III secretion system and virulence markers highlight similarities and differences between human- and plant-associated pseudomonads related to Pseudomonas fluorescens and P. putida.

Authors:  Sylvie Mazurier; Annabelle Merieau; Dorian Bergeau; Victorien Decoin; Daniel Sperandio; Alexandre Crépin; Corinne Barbey; Katy Jeannot; Maïté Vicré-Gibouin; Patrick Plésiat; Philippe Lemanceau; Xavier Latour
Journal:  Appl Environ Microbiol       Date:  2015-01-30       Impact factor: 4.792

3.  Key role for efflux in the preservative susceptibility and adaptive resistance of Burkholderia cepacia complex bacteria.

Authors:  Laura Rushton; Andrea Sass; Adam Baldwin; Christopher G Dowson; Denise Donoghue; Eshwar Mahenthiralingam
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

4.  Cepacia-like syndrome caused by Burkholderia multivorans.

Authors:  George Zahariadis; Michelle H Levy; Jane L Burns
Journal:  Can J Infect Dis       Date:  2003-03

5.  Diagnostics method for the rapid quantitative detection and identification of low-level contamination of high-purity water with pathogenic bacteria.

Authors:  Elizabeth Minogue; Kate Reddington; Siobhan Dorai-Raj; Nina Tuite; Eoin Clancy; Thomas Barry
Journal:  J Ind Microbiol Biotechnol       Date:  2013-06-20       Impact factor: 3.346

6.  Environmental Burkholderia cepacia complex isolates in human infections.

Authors:  Adam Baldwin; Eshwar Mahenthiralingam; Pavel Drevinek; Peter Vandamme; John R Govan; David J Waine; John J LiPuma; Luigi Chiarini; Claudia Dalmastri; Deborah A Henry; David P Speert; David Honeybourne; Martin C J Maiden; Chris G Dowson
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

7.  Long-term colonization of the cystic fibrosis lung by Burkholderia cepacia complex bacteria: epidemiology, clonal variation, and genome-wide expression alterations.

Authors:  Carla P Coutinho; Sandra C Dos Santos; Andreia Madeira; Nuno P Mira; Ana S Moreira; Isabel Sá-Correia
Journal:  Front Cell Infect Microbiol       Date:  2011-12-02       Impact factor: 5.293

8.  The exopolysaccharide gene cluster Bcam1330-Bcam1341 is involved in Burkholderia cenocepacia biofilm formation, and its expression is regulated by c-di-GMP and Bcam1349.

Authors:  Mustafa Fazli; Yvonne McCarthy; Michael Givskov; Robert P Ryan; Tim Tolker-Nielsen
Journal:  Microbiologyopen       Date:  2012-12-25       Impact factor: 3.139

9.  Effect of environmental factors on biofilm formation by clinical Stenotrophomonas maltophilia isolates.

Authors:  G Di Bonaventura; S Stepanović; C Picciani; A Pompilio; R Piccolomini
Journal:  Folia Microbiol (Praha)       Date:  2007       Impact factor: 2.629

10.  Burkholderia lata Infections from Intrinsically Contaminated Chlorhexidine Mouthwash, Australia, 2016.

Authors:  Lex E X Leong; Diana Lagana; Glen P Carter; Qinning Wang; Kija Smith; Tim P Stinear; David Shaw; Vitali Sintchenko; Steven L Wesselingh; Ivan Bastian; Geraint B Rogers
Journal:  Emerg Infect Dis       Date:  2018-11       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.